DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,490,000 | -54.8% | 73,902 | -16.3% | 0.00% | -50.0% |
| Q2 2021 | $3,295,000 | +70.5% | 88,342 | +16.9% | 0.00% | +100.0% |
| Q1 2021 | $1,933,000 | -19.1% | 75,585 | -30.3% | 0.00% | 0.0% |
| Q4 2020 | $2,388,000 | +27.0% | 108,428 | +3.8% | 0.00% | 0.0% |
| Q3 2020 | $1,880,000 | -33.2% | 104,492 | -5.7% | 0.00% | -50.0% |
| Q2 2020 | $2,816,000 | +436.4% | 110,865 | +287.6% | 0.00% | – |
| Q1 2020 | $525,000 | -67.4% | 28,603 | -60.9% | 0.00% | -100.0% |
| Q4 2019 | $1,612,000 | +291.3% | 73,173 | +155.3% | 0.00% | – |
| Q3 2019 | $412,000 | -31.3% | 28,667 | -24.6% | 0.00% | -100.0% |
| Q2 2019 | $600,000 | -8.1% | 38,040 | -14.7% | 0.00% | 0.0% |
| Q1 2019 | $653,000 | +118.4% | 44,594 | +59.2% | 0.00% | – |
| Q4 2018 | $299,000 | +22.0% | 28,020 | +74.1% | 0.00% | – |
| Q3 2018 | $245,000 | -0.8% | 16,095 | -20.4% | 0.00% | – |
| Q2 2018 | $247,000 | +311.7% | 20,221 | +97.4% | 0.00% | – |
| Q3 2016 | $60,000 | -63.2% | 10,245 | -81.1% | 0.00% | – |
| Q2 2016 | $163,000 | -13.8% | 54,112 | +240.6% | 0.00% | – |
| Q4 2015 | $189,000 | +5.6% | 15,886 | +23.8% | 0.00% | – |
| Q2 2015 | $179,000 | +12.6% | 12,833 | +2.4% | 0.00% | – |
| Q3 2014 | $159,000 | – | 12,536 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|